早产临产症状孕妇7天内自发性早产风险预测模型的开发与验证(QUIDS研究)
该研究基于5项欧洲前瞻性队列的个体 participant 数据荟萃分析(1783名孕妇)开发了包含阴道胎儿纤维连接蛋白定量值与临床危险因素的7天内自发性早产风险预测模型,并在英国26中心前瞻性队列(2924名孕妇)中外部验证,模型区分度良好(AUC 0.89),且在风险阈值≥2%时相比定性fFN具有成本效果。
要点
- 模型纳入定量阴道fFN、当前吸烟、非白人种族、未产和双胎/多胎妊娠。
- 内部验证AUC 0.89(95%CI 0.86–0.92),外部验证AUC 0.89(95%CI 0.84–0.94)。
- 在预测风险0%–10%范围内校准良好,更高风险时存在低估。
核心结论
- 包含阴道fFN浓度和临床危险因素的模型在预测测试后7天内自发性早产方面显示出良好性能,有潜力辅助临床决策。
- 该模型仍需在临床实践中进一步评估以确定能否改善临床结局。
研究设计与样本
- 开发与内部验证:5项欧洲前瞻性队列研究的个体 participant 数据荟萃分析(2009–2016年,1783名孕妇)。
- 外部验证:英国26个中心的前瞻性队列研究(2016–2018年,2924名孕妇)。
- 纳入人群为孕22+0至34+6周、有早产临产症状和体征的孕妇。
主要发现
- 开发队列中7天内自发性早产139例(7.8%),外部验证队列中85例(2.9%)。
- 内部验证乐观调整后AUC为0.89(95%CI 0.86–0.92),Nagelkerke R²为35%(95%CI 33%–37%)。
- 外部验证AUC为0.89(95%CI 0.84–0.94),Nagelkerke R²为36%(95%CI 34%–38%)。
- 校准曲线显示预测风险0%–10%范围内预测值与观察值接近,更高风险处存在低估(斜率1.24,95%CI 1.23–1.26)。
- 在风险阈值高达约15%时,模型净获益高于「全部治疗」或「不治疗」策略。
关键数值与推荐
- 模型预测7天内自发性早产,纳入变量:定量阴道fFN、当前吸烟、非白人种族、未产、多胎妊娠。
- 经济分析显示,在因7天内早产风险≥2%而收治入院的阈值下,该预后模型相比使用定性fFN具有成本效果。
临床怎么用
- 对于有早产临产症状的孕妇,可结合定量阴道fFN和临床危险因素评估7天内自发性早产风险。
- 模型在低风险范围(0%–10%)校准良好,可用于辅助排除和分层管理。
- 在高风险范围模型可能低估风险,临床解读时需谨慎。
局限性
- 开发数据集中非白人参与者数量有限。
- 开发数据集中某些变量存在缺失数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Timely interventions in women presenting with preterm labour can substantially improve health outcomes for preterm babies. However, establishing such a diagnosis is very challenging, as signs and symptoms of preterm labour are common and can be nonspecific. We aimed to develop and externally validate a risk prediction model using concentration of vaginal fluid fetal fibronectin (quantitative fFN), in combination with clinical risk factors, for the prediction of spontaneous preterm birth and assessed its cost-effectiveness. METHODS AND FINDINGS: Pregnant women included in the analyses were 22+0 to 34+6 weeks gestation with signs and symptoms of preterm labour. The primary outcome was spontaneous preterm birth within 7 days of quantitative fFN test. The risk prediction model was developed and internally validated in an individual participant data (IPD) meta-analysis of 5 European prospective cohort studies (2009 to 2016; 1,783 women; mean age 29.7 years; median BMI 24.8 kg/m2; 67.6% White; 11.7% smokers; 51.8% nulliparous; 10.4% with multiple pregnancy; 139 [7.8%] with spontaneous preterm birth within 7 days). The model was then externally validated in a prospective cohort study in 26 United Kingdom centres (2016 to 2018; 2,924 women; mean age 28.2 years; median BMI 25.4 kg/m2; 88.2% White; 21% smokers; 35.2% nulliparous; 3.5% with multiple pregnancy; 85 [2.9%] with spontaneous preterm birth within 7 days). The developed risk prediction model for spontaneous preterm birth within 7 days included quantitative fFN, current smoking, not White ethnicity, nulliparity, and multiple pregnancy. After internal validation, the optimism adjusted area under the curve was 0.89 (95% CI 0.86 to 0.92), and the optimism adjusted Nagelkerke R2 was 35% (95% CI 33% to 37%). On external validation in the prospective UK cohort population, the area under the curve was 0.89 (95% CI 0.84 to 0.94), and Nagelkerke R2 of 36% (95% CI: 34% to 38%). Recalibration of the model's intercept was required to ensure overall calibration-in-the-large. A calibration curve suggested close agreement between predicted and observed risks in the range of predictions 0% to 10%, but some miscalibration (underprediction) at higher risks (slope 1.24 (95% CI 1.23 to 1.26)). Despite any miscalibration, the net benefit of the model was higher than "treat all" or "treat none" strategies for thresholds up to about 15% risk. The economic analysis found the prognostic model was cost effective, compared to using qualitative fFN, at a threshold for hospital admission and treatment of ≥2% risk of preterm birth within 7 days. Study limitations include the limited number of participants who are not White and levels of missing data for certain variables in the development dataset. CONCLUSIONS: In this study, we found that a risk prediction model including vaginal fFN concentration and clinical risk factors showed promising performance in the prediction of spontaneous preterm birth within 7 days of test and has potential to inform management decisions for women with threatened preterm labour. Further evaluation of the risk prediction model in clinical practice is required to determine whether the risk prediction model improves clinical outcomes if used in practice. TRIAL REGISTRATION: The study was approved by the West of Scotland Research Ethics Committee (16/WS/0068). The study was registered with ISRCTN Registry (ISRCTN 41598423) and NIHR Portfolio (CPMS: 31277).
引用
- Stock SJ, Horne M, Bruijn M, et al. Development and validation of a risk prediction model of preterm birth for women with preterm labour symptoms (the QUIDS study): A prospective cohort study and individual participant data meta-analysis. PLoS Med. 2021. PMID: 34228732. doi:10.1371/journal.pmed.1003686
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。